|

Z-endoxifen Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: endoxifen

Pipeline

Phase 2: 3

Top Sponsors

  • QuantumLeap Healthcare Collaborative2
  • Atossa Therapeutics, Inc.1

Indications

  • Breast Cancer3
  • Cancer3
  • HER2-negative Breast Cancer2
  • Breast Neoplasms2
  • Hormone Receptor Negative Tumor1

Birmingham, Alabama1 trial

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

University of Alabama at Birmingham

Phase 2

Phoenix, Arizona1 trial

(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Mayo Clinic Arizona

Phase 2

Berkeley, California1 trial

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

Berkeley Outpatient Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.